| Social Determinants of Health |
1 |
1 |
| Thromboembolism |
0 |
0.76 |
| Estrogen |
0 |
0.98 |
| Surgery |
0 |
0.9 |
| Transgender |
0 |
0.41 |
| Testosterone |
0 |
0.99 |
| Testosterone Therapy |
0 |
0.97 |
| Breast |
0 |
0.2 |
| Clinical Guidelines |
0 |
0.2 |
| Fertility |
0 |
0.2 |
| Contraception |
0 |
0.18 |
| Adolescent Medicine |
0 |
0.14 |
| Birth |
0 |
0.14 |
| Fellowship |
0 |
0.14 |
| Preoperative |
0 |
0.14 |
| Venous Thromboembolism (VTE) |
0 |
0.14 |
| Red Blood Cell Count |
0 |
0.1 |
| Blood |
0 |
0.07 |
| Bone |
0 |
0.07 |
| Endocrine Society |
0 |
0.07 |
| Face |
0 |
0.07 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.07 |
| Hormonal Therapy |
0 |
0.07 |
| Hyperkalemia |
0 |
0.07 |
| Hypogonadism |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| Postoperative |
0 |
0.07 |
| Progestin |
0 |
0.07 |
| Referral |
0 |
0.07 |
| Steroids |
0 |
0.07 |
| Transdermal |
0 |
0.07 |